Researchers are learning more about ways to predict the likelihood of newborn complications from early in pregnancy using samples provided by the Indiana University School of Medicine Building Blocks of Pregnancy Biobank.
Researchers at Indiana University School of Medicine have published their work about a specific type of childhood cancer in the peer-reviewed, international oncology journal, Cancers. This research involves a combination therapy that significantly slows tumor growth in models, which includes a model established from cells taken from tumors donated by Tyler Trent.
Indiana University School of Medicine announced today that several Hoosier volunteers are now enrolled in the late stage clinical study of an investigational COVID-19 vaccine known as AZD1222, taking place at IU Health University Hospital. Within days of announcing IU School of Medicine as one of the study sites, more than 3,000 Hoosiers created volunteer profiles through All IN for Health, a program of the Indiana Clinical and Translational Sciences Institute (CTSI).
Scientists have found that insulin has met an evolutionary cul-de-sac, limiting its ability to adapt to obesity and thereby rendering most people vulnerable to Type 2 diabetes. A recent study from scientists at Indiana University School of Medicine, the University of Michigan and Case Western Reserve University has determined that the sequence of insulin has become entrenched at the edge of impaired production, an intrinsic vulnerability unmasked by rare mutations in the insulin gene causing diabetes in childhood
Indiana University School of Medicine is partnering with the Northwest Indiana GME Consortium to launch a new psychiatry residency program at its regional campus in northwest Indiana aimed at treating an underserved population in that part of the state.
Researchers at Indiana University School of Medicine are hoping to develop a new model to help those who experience a traumatic brain injury (TBI) recover and better manage challenges that result from their injury.
The Walther Cancer Foundation will invest $11 million to advance collaborative cancer research at Indiana University and Purdue University by supporting scientists through bioinformatics — an increasingly critical aspect of their work.
Indiana University School of Medicine has announced the hiring of a world-recognized medical oncologist and multiple myeloma researcher to lead the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, bolstered by a $15 million fund established by the Walther Cancer Foundation to support him in this role.